[1]
“Explicit versus implicit risk assessment for the indication of antithrombotic prophylaxis in acutely ill medical in-patients”, Swiss Med Wkly, vol. 135, no. 1516, pp. 228–234, Apr. 2005, doi: 10.4414/smw.2005.10992.